LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Abbott Laboratories
Headquarters:
Abbott Park, IL, United States
Website:
http://www.abbott.com
Year Founded:
1900
Status:
Public
Industry Sector:
HealthTechnology
CEO:
Robert B. Ford, MBA
Number Of Employees:
114,000
Enterprise Value:
$205,261,280,000
PE Ratio:
16.95
Exchange/Ticker 1:
NYSE:ABT
Exchange/Ticker 2:
N/A
Latest Market Cap:
$226,987,802,624
BioCentury
|
Dec 12, 2024
Management Tracks
Two more C-suite hires at Xaira
Plus: Accent’s Copeland to retire and updates from ProQR, Kashiv and Aculeus
Read More
BioCentury
|
Nov 21, 2024
Finance
Versant-backed Pep2Tango taking four-way agonist to clinic for obesity
Program designed to reduce weight while sparing muscle mass, GI effects headed for IND next year
Read More
BioCentury
|
Mar 6, 2024
Management Tracks
EyePoint names Ribeiro CMO
Plus: Ford joins Prothena and updates from Atlas, Osmol and CytoVale
Read More
BioCentury
|
Jan 24, 2024
Management Tracks
Markison to succeed Heino as Lantheus CEO
Plus: Lisa Olson becomes CEO of Enthera, and updates from Bayer, Neumora, PDS and more
Read More
BioCentury
|
Dec 7, 2023
Deals
AbbVie sees Cerevel’s antipsychotic as ‘best-in-class’ driver of $8.7B deal
Again investing outside immunology, pharma sees differentiation in potential competitor with Karuna’s registrational schizophrenia therapy
Read More
BioCentury
|
Sep 6, 2023
Management Tracks
Novartis shuffles AbbVie’s Horber in, commercial chief Tschudin out
Latest management changes are part of a broader reshaping of the organization as it seeks greater market share in the U.S.
Read More
BioCentury
|
Mar 30, 2023
Management Tracks
BeiGene hires a global head of diversity and health equity
Plus: Mahmood leaving Nkarta for CEO role and updates from CIRM, CFF
Read More
BioCentury
|
Nov 22, 2022
Management Tracks
New CEOs named at Oxford, Angelini
Plus: Hegde becomes CSO at Congruence, and updates from Medivir and Grunenthal
Read More
BioCentury
|
Sep 6, 2022
Management Tracks
Owkin names Google’s Vert as chief R&D officer
Plus new chief scientific and medical officer at Ray Therapeutics, and updates from Ansa, Walking Fish and more
Read More
BioCentury
|
May 4, 2022
Management Tracks
Hickey returns to U.S. for new role at Pfizer
Plus Kaundinya named president and CEO at GlycoERA, and updates from Plexium, Alentis, ADCendo, Xcell and more
Read More
Items per page:
10
1 - 10 of 2564